Purity of CD138+-MM cells was proven by checking SDC1 (CD138) gene expression and a set of established myeloma-marker/differentiation factors, such as MZB1 (marginal zone B and B1 cell-specific protein), XBP1 (x-box binding protein 1), IRF4 (interferon regulatory factor 4, MUM-1), SLAM7 (activating transcription factor 4), and TNF receptor superfamily member 17 (BCMA) in direct comparison to PBMNCs of healthy donors (Figure 4B). This evidence concerns the gene MZB1 and Miyoshi myopathy.